MAPT and Parkinson disease: Consistent with these models’ observations, DaT-SPECT and CSF p-tau biomarkers were significantly different between groups (HC-MCI vs PD-MCI), thus suggesting that the DaT + p-tau and DaT + Aβ42 + p-tau combinations are better options (S1b Table).